VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

VJVirtual | RWD from INSIGHT-MM: duration of therapy and treatment sequencing

Guy Pratt, MD, FRCP, FRCPath, of University of Birmingham, Birmingham, UK, highlights data coming from a UK-specific analysis of the INSIGHT MM study (NCT02761187). This analysis showed a clear variability in treatment selection and sequencing and treatment discontinuation in UK practice for patients with multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter